- AU$4.34m
- AU$4.72m
- AU$4.45m
Brief: Audeara Formally Commences Process To Establish US OTCID Quotation
Brief: Audeara FY Revenues From Ordinary Activities A$4.4 Million
Brief: Audeara Set To Raise A$1.26 Million Via Placement
Brief: Audeara Seeks Trading Halt
Brief: Audeara Says Chip-Level AI Licensing Partnership Enters Commercial Production
Brief: Audeara Secures Exclusive Deal With Shokz Health Global
Brief: Audeara Posts Unaudited Group Revenues Of A$1M For Quarter
Brief: Audeara Secures Chip-Level AI Audio Licensing Deal
Australia's Audeara surges on China regulatory win for hearing tech
Brief: Audeara Says NMPA Secured For China Hearing Aid Launch
Australia's Audeara hits near 20-month high on purchase order from Eastech unit
Brief: Audeara Announces Distribution Agreement With Eyear System To Launch Auracast Accessibility In Japan
Brief: Audeara Signs Licensing Agreement Secured With Eastech (Huizhou)
Australia's Audeara rises on upbeat trading update
Brief: Audeara Says FY25 Unaudited Revenue From June 2024 To May 2025 Exceeds A$3.64M
Brief: Audeara Says Reseller Agreement Secured With George & Matilda Eyecare
Australia's Audeara jumps over 20% on order win
Brief: Audeara Says Clinico-Branded Products Officially Launched In Taiwan
Brief: Audeara Ltd Announces Strategic Placement To Raise A$1.35 Million